# The Future of Glioblastoma Treatment | Edward Chang, M.D.

**Channel:** Peter Attia MD
**Upload Date:** 2025-09-10
**URL:** https://www.youtube.com/watch?v=56hRRr_B7kg
**Duration:** 8 minutes

## Description

Get An Introductory Guide to Longevity and my weekly newsletter here (free): https://bit.ly/46mujcA
Watch the full episode: https://youtu.be/y7LXTyUhSVM
Become a member to receive exclusive content: https://bit.ly/3JJnskJ

This clip is from episode  #363 ‒ A new frontier in neurosurgery: restoring brain function with brain-computer interfaces, advancing glioblastoma care, and new hope for devastating brain diseases | Edward Chang, M.D.

In this clip, they discuss:

- What Is GBM? – Glioblastoma multiforme originates from glial support cells in the brain
- From Histology to Genetics – Diagnosis has advanced from tissue slides to detailed genetic profiling
- Targeted Treatments – Emerging chemotherapy agents focus on genetic mechanisms rather than broad cell cycle disruption
- Immune System Evasion – GBMs suppress immune detection, growing in “stealth”
- Future Therapies – Combination approaches—surgery, targeted drugs, immunotherapy, and advanced delivery—may change outcomes

--------
About:

The Peter Attia Drive is a deep-dive podcast focusing on maximizing longevity, and all that goes into that from physical to cognitive to emotional health. With over 90 million episodes downloaded, it features topics including exercise, nutritional biochemistry, cardiovascular disease, Alzheimer’s disease, cancer, mental health, and much more.

Peter Attia is the founder of Early Medical, a medical practice that applies the principles of Medicine 3.0 to patients with the goal of lengthening their lifespan and simultaneously improving their healthspan. 

Learn more: https://peterattiamd.com

Connect with Peter on:
Facebook: http://bit.ly/PeterAttiaMDFB
Twitter: http://bit.ly/PeterAttiaMDTW
Instagram: http://bit.ly/PeterAttiaMDIG

Subscribe to The Drive:
Apple Podcast: http://bit.ly/TheDriveApplePodcasts
Overcast: http://bit.ly/TheDriveOvercast
Spotify: http://bit.ly/TheDriveSpotify
Google Podcasts: http://bit.ly/TheDriveGoogle

Disclaimer: This podcast is for general informational purposes only and does not constitute the practice of medicine, nursing, or other professional healthcare services, including the giving of medical advice. No doctor-patient relationship is formed. The use of this information and the materials linked to this podcast is at the user's own risk. The content on this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard or delay in obtaining medical advice for any medical condition they have, and they should seek the assistance of their healthcare professionals for any such conditions. I take conflicts of interest very seriously. For all of my disclosures and the companies I invest in or advise, please visit my website where I keep an up-to-date and active list of such companies. For a full list of our registered and unregistered trademarks, trade names, and service marks, please review our Terms of Use: https://peterattiamd.com/terms-of-use/

## AI Summary

I'll help structure an analysis of this episode segment about glioblastoma (GBM) treatment with Dr. Edward Chang. Note that this appears to be only a portion of the full episode, so my analysis will be limited to the content provided.

1. **Executive Summary**:
This segment focuses on glioblastoma multiforme (GBM), featuring Dr. Edward Chang discussing the current state and future of GBM treatment. The conversation covers the fundamental nature of GBMs, their genetic complexity, and emerging treatment approaches. Key themes include the transition from purely histological diagnosis to molecular profiling, the challenges of the blood-brain barrier, and the potential of new therapeutic strategies including immunotherapy and focused ultrasound.

2. **Key Medical/Scientific Points**:
- GBM originates from glial (support) cells in the brain, characterized by rapid growth and necrosis [00:00:00]
- Modern diagnosis includes genetic profiling, not just histological examination [00:01:37]
- GBMs actively suppress parts of the immune system [00:03:17]
- More extensive surgical resection correlates with longer survival, but isn't curative [00:03:17]
- GBM is polygenic and rarely shows the same set of mutations between cases [00:04:00]

3. **Health Optimization Tips**:
No specific health optimization tips were provided in this segment.

4. **Supplements & Medications**:
- Reference to chemotherapy agents targeting specific genetic mechanisms [00:02:03]

7. **Biomarkers & Testing**:
- Genetic profiling of tumors is now standard at academic medical centers [00:02:03]
- MRI imaging for tumor visualization [00:03:17]

8. **References & Resources**:
Expert featured:
- Dr. Edward Chang, discussing neurosurgery and GBM treatment [throughout segment]

9. **Notable Quotes**:
"We're moving from an era where we use a visualization of the histology now to this molecular profiling which is more mechanistic." [00:02:03]

10. **Follow-up Questions**:
1. What specific genetic mutations are most commonly found in GBM cases?
2. How effective is focused ultrasound in penetrating the blood-brain barrier?
3. What are the success rates of current immunotherapy approaches for GBM?
4. How do survival rates vary based on the extent of surgical resection?

Note: Several requested categories (Exercise & Movement, Nutrition & Diet, etc.) were not discussed in this segment of the episode.
